Projects per year
Areas covered: Pubmed and Web of Science were used to search for literature relevant to BNP and the use of allogeneic vaccine cell lines. Following a review of the pathology and pathogenesis of this novel condition, we discuss potential risks associated with the use of allogeneic vaccine cell lines.
Expert commentary: Although BNP is associated with a specific vaccine, it highlights safety concerns common to all vaccines produced using allogeneic cell lines. Measures to prevent similar vaccine-induced alloimmune-mediated adverse events in the future are discussed.
- Vaccine safety
- Vaccine production
- Neonatal Pancytopenia (BNP)
- Major Histocompatibility Complex class I (MHC I)
- Cell line
FingerprintDive into the research topics of 'The risks of using allogeneic cell lines for vaccine production: The example of Bovine Neonatal Pancytopenia'. Together they form a unique fingerprint.
- 2 Finished
Collie, D., Beard, P., Bishop, S., Bronsvoort, M., Burt, D., Fitzgerald, R., Freeman, T., Gally, D., Gill, A., Glass, E., Hocking, P., Hope, J., Hume, D., Kaiser, P., Mabbott, N., McLachlan, G., Morrison, L., Stevens, J., Stevens, M. & Watson, M.
1/04/12 → 31/03/17
1/09/10 → 30/09/13
Project: University Awarded Project Funding